XML 55 R44.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue Recognition - Deferred Revenues (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Revenue recognized during the period that was included in deferred revenues at the beginning of the period $ 9,418 $ 7,048    
Deferred revenue, current portion 20,557   $ 19,754  
Deferred revenue, Long-term 16,705   16,838  
Deferred revenue 37,262 $ 36,533 36,592 $ 35,740
BGI Genomics        
Deferred revenue, current portion 500      
Deferred revenue, Long-term 16,700      
Deferred revenue 17,200   $ 17,300  
Foundation Medicine ("FMI")        
Deferred revenue, current portion 1,500      
BGI Genomics and Foundation Medicine        
Revenue recognized during the period that was included in deferred revenues at the beginning of the period 400      
Genetic testing services        
Revenue recognized during the period that was included in deferred revenues at the beginning of the period 9,000      
Deferred revenue, current portion $ 18,600